scholarly journals Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study

2018 ◽  
Vol 18 ◽  
pp. S204-S205 ◽  
Author(s):  
Courtney D. DiNardo ◽  
Eytan M. Stein ◽  
Stéphane de Botton ◽  
Gail J. Roboz ◽  
Jessica K. Altman ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Refractory Acute Myeloid Leukemia ◽  
Mutant Idh1 ◽  
Acute Myeloid

Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 7000-7000 ◽  
Author(s):  
Daniel Aaron Pollyea ◽  
Courtney Denton Dinardo ◽  
Stéphane de Botton ◽  
Eytan Stein ◽  
Gail J. Roboz ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Refractory Acute Myeloid Leukemia ◽  
Mutant Idh1 ◽  
Acute Myeloid

Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 7044-7044 ◽  
Author(s):  
Jorge E. Cortes ◽  
Stefan Faderl ◽  
John Pagel ◽  
Chul Won Jung ◽  
Sung-Soo Yoon ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myelodysplastic Syndrome ◽  
Myeloid Leukemia ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Refractory Acute Myeloid Leukemia ◽  
Acute Myeloid

scholarly journals Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study

2018 ◽  
Vol 109 (10) ◽  
pp. 3235-3244 ◽  
Author(s):  
Kensuke Usuki ◽  
Toru Sakura ◽  
Yukio Kobayashi ◽  
Toshihiro Miyamoto ◽  
Hiroatsu Iida ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Phase 1 ◽  
Japanese Patients ◽  
Clinical Profile ◽  
Open Label ◽  
Phase 1 Study ◽  
Open Label Phase ◽  
Refractory Acute Myeloid Leukemia ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document